Top Story

New next-generation sequencing test launched for thyroid nodules

December 20, 2014

Interpace Diagnostics, a molecular diagnostics subsidiary of PDI, Inc., has recently launched a new next-generation sequencing test designed to determine the difference between benign and malignant genotypes of thyroid nodules, according to a release from the company.

The test, ThyGenX, can be used to help physicians reduce unnecessary surgery. Eight genes associated with papillary and follicular carcinoma make up the panel of genes tested.

In the Journals

Lower risk for type 2 diabetes among people with type O blood

December 19, 2014
People with the blood types A, B and AB have a higher risk for developing type 2 diabetes than those with type O, according to recent study findings published in…
In the Journals

Nonenhanced neck CT may detect diffuse thyroid disease

December 19, 2014
Nonenhanced CT images are effective for differentiating diffuse thyroid disease from normal thyroid, according to recent findings published in the International Journal

CMS releases new quality of care data on physicians, ACOs, hospitals

December 19, 2014
CMS released new data on the quality of care provided by physician group practices, hospitals and Accountable Care Organizations, according to the CMS Blog.Included in…
Health Care Updates

New guidelines recommend off-loading to increase likelihood of diabetic foot ulcer healing

December 19, 2014
Relieving pressure on the foot through the use of off-loading improves healing outcomes and reduces complications in patients with diabetic foot ulcers, according to…
More News Headlines »
CME
Acromegaly Cases

Acromegaly Cases: Expert Insights into Diagnosis and Emerging Treatment Options – Part 5 of 5

This activity is supported by an educational grant from Genentech.

Acromegaly is a rare chronic disorder that is typically caused by excessive growth hormone secretion, and is…
More »
Meeting News Coverage Video
thumbnail for video 3890508474001

Lenvatinib, sorafenib may significantly impact treatment of differentiated thyroid cancer

November 13, 2014
Marcia S. Brose, MD, PhD, associate professor at the University of Pennsylvania and director of the thyroid cancer…
More »
CME
Acromegaly: Challenges in Diagnosis - Part 2 of 5

Acromegaly: Challenges in Diagnosis - Part 2 of 5

This activity is supported by an educational grant from Genentech.

The diagnosis of acromegaly is often not made until 7 to 10 years after symptom onset. Contributing factors include low…
More »